1. Home
  2. COLL vs PXED Comparison

COLL vs PXED Comparison

Compare COLL & PXED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.40

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$30.81

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
COLL
PXED
Founded
2002
1976
Country
United States
United States
Employees
N/A
3400
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
COLL
PXED
Price
$32.40
$30.81
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$51.17
$44.29
AVG Volume (30 Days)
547.7K
55.1K
Earning Date
05-07-2026
04-07-2026
Dividend Yield
N/A
2.74%
EPS Growth
N/A
N/A
EPS
1.73
N/A
Revenue
$780,567,000.00
N/A
Revenue This Year
$5.93
$4.45
Revenue Next Year
N/A
$4.66
P/E Ratio
$19.32
$11.20
Revenue Growth
23.62
N/A
52 Week Low
$23.23
$23.52
52 Week High
$50.79
$38.19

Technical Indicators

Market Signals
Indicator
COLL
PXED
Relative Strength Index (RSI) 24.32 56.83
Support Level $31.01 $29.78
Resistance Level $32.92 $31.13
Average True Range (ATR) 1.30 1.60
MACD -0.04 0.39
Stochastic Oscillator 1.07 71.92

Price Performance

Historical Comparison
COLL
PXED

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

Share on Social Networks: